The CRISPR CFO change took effect on October 19, 2026, with A.J. Silver succeeding Raju Prasad as chief financial officer of CRISPR Therapeutics. Silver was promoted from senior vice president of finance, while Prasad resigned to pursue external opportunities.
Key Takeaways
- Silver assumed the CFO role immediately, along with responsibility as principal financial officer and principal accounting officer.
- Prasad is expected to remain an employee until a date on or before November 30, 2026.
- The company said Prasad’s resignation did not stem from disagreements over operations, accounting or financial controls.
Table of Contents
- CRISPR CFO change takes effect before Prasad’s departure
- Silver brings eight years of company experience
- Employment agreement sets pay and retention terms
- Conclusion
CRISPR CFO change takes effect before Prasad’s departure
CRISPR Therapeutics’ October 19 leadership filing separates the immediate transfer of CFO responsibilities from Prasad’s expected employment end date. Andrew J. Silver, known as A.J., has already taken over the finance leadership position rather than waiting for Prasad to leave the company.
The filing states that Prasad’s decision did not result from any disagreement concerning the company’s operations, policies or practices. That disclosure specifically includes financial statements, accounting policies and judgments, internal control over financial reporting, and disclosure controls.
Chairman and Chief Executive Officer Samarth Kulkarni thanked Prasad for his leadership of the finance organization and relationships with investors. Prasad said he had decided it was the right time to take the next step in his career.
| Item | Details |
|---|---|
| Annual base salary | $515,000 |
| Target annual bonus | 45% of annual base salary |
| One-time promotion award | 25,000 restricted stock units |
Silver brings eight years of company experience
Silver joined CRISPR Therapeutics in October 2018 and became senior vice president of finance in January 2025. His responsibilities have spanned strategic finance, treasury, financial planning and analysis, accounting and reporting, tax, and financial operations.
Before joining the company, he spent more than 10 years at Ernst & Young, most recently as a senior manager in assurance services, and became a certified public accountant. He holds a master’s degree in accounting from the University of Connecticut and a bachelor’s degree from Boston College.
Kulkarni cited Silver’s knowledge of the business and operational experience in explaining the internal promotion.
Employment agreement sets pay and retention terms
Silver’s employment agreement, dated October 19, includes base pay, an annual incentive opportunity and a one-time equity award. His 2026 bonus will be prorated to reflect the promotion’s effective date.
The restricted stock units are scheduled to vest in full on the second anniversary of the grant date, subject to continued service. The agreement also provides a six-month notice period for termination without cause or resignation for good reason, with compensation and equity vesting continuing during that period.
Conclusion
Silver’s appointment is effective, making Prasad’s expected employment departure on or before November 30, 2026, the next stated transition milestone.
Read More News
Disclaimer
This FinanceVelix article provides general information, not personalized financial, investment, legal, or tax advice. Market prices, interest rates and economic conditions can change; investments carry a risk of loss. Facts reflect the material available when published and may change. Check important information independently and consult a qualified professional when needed. Mentioning an asset, company, or service is not an endorsement.
